Literature DB >> 22108057

MLVA genotyping of Chinese human Brucella melitensis biovar 1, 2 and 3 isolates.

Hai Jiang1, Mengguang Fan, Jingdiao Chen, Jingchuan Mi, Ruiping Yu, Hongyan Zhao, Dongri Piao, Changwen Ke, Xiaoling Deng, Guozhong Tian, Buyun Cui.   

Abstract

BACKGROUND: Since 1950, Brucella melitensis has been the predominant strain associated with human brucellosis in China. In this study we investigated the genotypic characteristics of B. melitensis isolates from China using a multiple-locus variable-number tandem-repeat analysis (MLVA) and evaluated the utility of MLVA with regards to epidemiological trace-back investigation.
RESULTS: A total of 105 B. melitensis strains isolated from throughout China were divided into 69 MLVA types using MLVA-16. Nei's genetic diversity indices for the various loci ranged between 0.00 - 0.84. 12 out 16 loci were the low diversity with values < 0.2 and the most discriminatory markers were bruce16 and bruce30 with a diversity index of > 0.75 and containing 8 and 7 alleles, respectively. Many isolates were single-locus or double-locus variants of closely related B. melitensis isolates from different regions, including the north and south of China. Using panel 1, the majority of strains (84/105) were genotype 42 clustering to the 'East Mediterranean' B. melitensis group. Chinese B. melitensis are classified in limited number of closely related genotypes showing variation mainly at the panel 2B loci.
CONCLUSION: The MLVA-16 assay can be useful to reveal the predominant genotypes and strain relatedness in endemic or non-endemic regions of brucellosis. However it is not suitable for biovar differentiation of B. melitensis. Genotype 42 is widely distributed throughout China during a long time. Bruce 16 and bruce 30 in panel 2B markers are most useful for typing Chinese isolates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108057      PMCID: PMC3233519          DOI: 10.1186/1471-2180-11-256

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


Background

Brucellosis, recognized as a common zoonotic disease globally, is caused by bacteria of the genus Brucella. B. melitensis, B. abortus, and B. suis remain the principal causes of human brucellosis worldwide and are major public health problems, primarily in Africa, the Middle East and Southeast Asia [1]. Brucellosis is prevalent in China, especially in the northern China, where people are economically dependent on ruminant livestock. Approximately 30,000 human cases are reported annually over the past 5 years [2]. In China, B. melitensis was the predominant strain associated with human brucellosis outbreaks, according to annual report on surveillance of selected infectious disease and vector. Species identification and subtyping of Brucella isolates is very important for epidemiologic surveillance and investigation of outbreaks in Brucella-endemic regions [3,4]. Recent studies have confirmed that multiple-locus variable-number tandem-repeat analysis (MLVA) is a useful tool for identifying and genotyping Brucella strains and the resultant data can be used for epidemiological trace-back investigations [3,5-8]. In efforts to better improve surveillance and evaluate the power of epidemiological trace-back in China, the MLVA-16 scheme was used to type a collection of 105 B. melitensis isolates from 18 different regions throughout China. (This study was presented in part at the 5th Brucellosis International Research Conference of the American Society for Microbiology, Buenos Aires, Argentina, 2011.)

Results

Typing and clustering of B. melitensis isolates by MLVA-16

Using the complete MLVA-16 assay (including panel 1, 2A and 2B loci), the 105 B. melitensis isolates were clustered in 69 different genotypes with 17 clusters and 52 singleton genotypes (Figure 1). The corresponding diversity index for panels 1, 2A, and 2B were 0.37, 0.11, and 0.98 respectively. The overall discriminatory index of MLVA-16 in this population was 0.99. Using panel 1, the present population clustered into five known genotypes and a new genotype. The five known genotypes were included in the previously named the 'East Mediterranean' group with genotypes 42 (83 strains), 43(5 strains), 45(3 strains), 58(4 strains) and 63(8 strains). All were included in the previously recognized 'East Mediterranean' group. Two strains from Guangdong, isolated in 2008, had the genotype (1-5-3-13-2-1-3-2), labeled as CN-1. The two strains were a single-locus variant (SLV) to genotype 42(1-5-3-13-2-2-3-2). To date the genotype associated with CN-1 has not been reported from any other country.
Figure 1

Dendrogram based on the MLVA-16 genotyping assay showing relationships of the 105 . MLVA type: panel 1 and panel 2 genotypes in this article; key: serial number for the isolate in the Brucella2010 MLVA database http://mlva-u-psud.fr/; strain: strain name in the laboratory in which the DNA extraction was done; province/year: province and year of isolation; panel1, panel 2A, panel 2B: genotypes corresponding to each isolates in the database for each set of loci; The actual biotyping result is indicated in the species-biovar column.

Dendrogram based on the MLVA-16 genotyping assay showing relationships of the 105 . MLVA type: panel 1 and panel 2 genotypes in this article; key: serial number for the isolate in the Brucella2010 MLVA database http://mlva-u-psud.fr/; strain: strain name in the laboratory in which the DNA extraction was done; province/year: province and year of isolation; panel1, panel 2A, panel 2B: genotypes corresponding to each isolates in the database for each set of loci; The actual biotyping result is indicated in the species-biovar column. Greater diversity among the Chinese B. melitensis isolates was apparent when the eight additional markers encompassing panel 2A and 2B were included. The number of strains populating a cluster ranged from two (eight clusters) to six. Clusters comprised of two strains were as follows: MLVA type009 (1-5-3-12-2-2-3-2-4-20-8-7-4-3-6-7), MLVA type027 (1-5-3-12-2-2-3-2-4-20-8-6-4-3-7-5), MLVA type031 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-9-5), MLVA type037 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-4-5), MLVA type045 (1-5-3-12-2-2-3-2-4-20-8-9-4-3-5-4), MLVA type047 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-5-4), MLVA type048 (1-5-3-12-2-2-3-2-4-22-8-5-4-3-5-5) and MLVA type050 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-5-5). Clusters comprised of three strains were as follows: MLVA type005 (1-5-3-12-2-2-3-2-4-20-8-7-4-3-6-7), MLVA type012 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-7-7) and MLVA type049 (1-5-3-12-2-2-3-2-4-23-8-5-4-3-5-5). Clusters comprised of four strains were as follows: MLVA type030 (1-5-3-12-2-2-3-2-4-20-8-7-4-3-9-5), MLVA type038 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-8-5) and MLVA type046 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-5-4). Clusters comprised of five strains were as follows: MLVA type011 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-7-5) and MLVA type018(1-5-3-12-2-2-3-2-4-20-8-5-4-3-8-6). Cluster comprised of six strains was MLVA type010 (1-5-3-12-2-2-3-2-4-20-8-5-4-3-7-6). Based upon the year of isolation, it is evident that many of the genotypes identified using MLVA-16 appear to have persisted for a long time in China and may be associated with spread of the strains from northern to southern China; more data will need to be collected to re-enforce these observations. The most discriminatory markers were bruce16 and bruce30 of panel 2B, with a diversity index of > 0.75 harboring 8 and 7 alleles, respectively. The most homogeneous markers, in contrast, were bruce06, bruce08, bruce11, bruce18, bruce21, bruce45 and bruce55 of panel 1 and panel 2A. The main characteristics of the 16 loci in the 105 B. melitensis strains are shown in Table 1.
Table 1

Main characteristics of 16 VNTR loci in 105 B. melitensis isolates

LocusRepeat size(bp)No. of allelesNo. of repeatsNei's DI and 95%CI
bruce06134110.00
bruce0818150.00
bruce1163130.00
bruce1215212-130.07(0.00-0.14)
bruce4212522-30.17(0.08-0.26)
bruce431231-30.25(0.15-0.36)
bruce4518130.00
bruce5540120.00
bruce188140.00
bruce196320,22-230.13(0.04-0.21)
bruce218180.00
bruce04873-90.47(0.36-0.58)
bruce07843-60.16(0.07-0.25)
bruce09861,3,6-90.13(0.04-0.23)
bruce16883-100.83(0.81-0.85)
bruce30873-90.75(0.71-0.79)
Main characteristics of 16 VNTR loci in 105 B. melitensis isolates

Analysis of the isolates from Inner Mongolia and Guangdong

Using the complete MLVA-16 assay, the 26 B. melitensis isolates from Inner Mongolia and 39 isolates from Guangdong were clustered in 20 and 27 different genotypes, respectively. The bruce16 loci had 6 and 7 alleles and the bruce30 loci had 6 and 5 alleles in these two population. 7 genotypes of 11 isolates from Inner Mongolia and 9 genotypes of 16 isolates from Guangdong isolates were single-locus or double locus variants of the main subgroups at 90% similarity. Only two of the clusters consisted of epidemiologically related strains exclusively from the same province and the same time. Bru0501 and bru0502 isolates came from a married couple who contacted with sheep fetuses and placenta in May, 1991 from Bai country, Xilinguole, Inner Mongolia. Bru0478, br0479, bru0480 and bru0481 isolates were collected over six weeks from late April to early June, 2010, in Pingsha county, Zhuhai city, Guangdong province. These four patients had not identified at-risk occupational history and experienced fever, debility and joint pains.

Trace-back of a laboratory-acquired Brucella infection

We report a case of brucellosis affecting a hospital microbiology laboratory technician in Beijing, a non-endemic area of China. To better elucidate the origin of such infection, Brucella strains from both the patient and the laboratory technician were characterized by MLVA-16. The strain BJ06-10 showed the same MLVA type with strain NM06-11 isolated from a patient with acute brucellosis who engaged in fur-making in Inner Mongolia.

Identification of the B. melitensis vaccine strain M5

LB10-01, a B. melitensis biovar 1 strain isolated from Guangdong in 2010 was indistinguishable from the vaccine strain M5 according to the MLVA cluster analysis (MLVA027: 1-5-3-13-2-2-3-2-4-20-8-6-4-3-7-5). This is unexpected since the vaccine strain M5 was not used in Guangdong. Detection of a strain with phenotypic and genotypic properties indistinguishable from the vaccine strain M5 raises the concern of the origin of the wild type strain.

Discussion

Brucellosis surveillance was started in 1980 in some parts of China. In 2008, 21 surveillance points for animal and human brucellosis were established in the 19 provinces of Heilongjiang, Jilin, Hebei, Henan, Inner Mongolia, Shandong, Guangdong, Guangxi, Sichuan, Tibet, Gansu, Ningxia, Xinjiang, Shanxi, Shan'xi, Zhejiang, Liaoning, Ningxia and Yunnan. Since the established of these surveillance points more than 30 years ago, a huge panel of animals and humans strains have been surveyed. It is significant that the national epidemiological characteristics can be analyzed. It suggests that B. melitensis isolates from different locations and years would reflect the epidemic features of human brucellosis. Sheep infected with Brucella are one of the main sources for human and animal brucellosis in China [9]. Over the last 20 years, the geographic distribution of brucellosis in China had been changing from pasturing areas to regions of with reduced agricultural interests (or alternatively more industrial concentrations); in these areas the infection rates, reported incidence, and number of outbreaks of brucellosis have increased markedly based on the National Notifiable Disease Surveillance System data. During this period, the cases have mostly been reported from Inner Mongolia, Shanxi, Hebei, Shandong, Henan, Liaoning, Jilin, Heilongjiang, and Shan'xi provinces. It is worth noting that brucellosis is endemic in Guangdong province, one of the wealthiest and industrial provinces in China. This is because of the movement of infected animal to Guangdong, resulting in the change of the geographic distribution of brucellosis. In the different epidemic regions of China, the predominant strains have been shown to be B. melitensis biovar 1, 2, or 3 [9]. Since 2005, most human cases in China have been caused by B. melitensis biovar 3 [10]. Classical typing systems are unable to subdivide Brucella isolates below the biovar level. Molecular typing methods such as MLVA have been utilized to distinguish between strains of the same biovar in both animal and human isolates [3,5,6,11-13]. In an effort to assess the value of MLVA as a subtyping tool for Brucella strains, genotypic characteristics of 105 B. melitensis isolates were investigated. Cluster analysis of these China strains, based on the eight variable-nucleotide tandem repeat loci included in the MLVA-16 panel 1 grouped them all into the B. melitensis 'East Mediterranean group' [3] and unique from circulating strains in Northern Africa, Southern Europe ('West Mediterranean group' and 'American group'). For instance, an (panel 1 genotype 42 and 43) clustered separately from most of the other 'West Mediterranean group' (panel 1 genotype 49 and 51) and 'American group'(panel 1 genotype 47). Previous studies have shown that Near Eastern countries frequently report human cases associated with genotypes 42 and 43 [3,14]. Genotype 42, as we have shown, is widely distributed throughout China, and has previously been reported to be predominant in Turkey, Portugal and Spain [13]. In Spain, human B. melitensis strains clustered into genotypes 42 (Eastern Mediterranean group, 55%), 48 and 53 (Americas group, ~11%) and 51 (Western Mediterranean group, ~8%). Chinese B. melitensis are classified in limited number of closely related genotypes showing variation mainly at the panel 2B loci. In China, the Inner Mongolia Autonomous Region is the most severe endemic focus of brucellosis, with an annual incidence of the disease varying from 40 to 70/100,000 during 2005-2010 [2]. Inner Mongolia is in close proximity to Heilongjiang, Jilin, Hebei and Shanxi provinces; these provinces are located in the north and east of China, where stocking raising is the most important aspect of the economy. In these regions, B. melitensis genotype 42 strains were predominant, but genotype 42 strains were also common in provinces reporting sporadic cases such as Liaoning, Shandong, Zhejiang, Fujian and Tianjin. These isolates were only single-locus or double-locus variants of B. melitensis from the endemic regions. Of particular note is the apparently stability of genotype 42 in China; genotype 42 strains were isolated from Inner Mongolia in1957 as well as 53 years later. Guangdong province, which is now considered to be an endemic region for brucellosis, is located in the southern coastal region of China, where the incidence of human brucellosis has increased gradually since 2000. The prevailing panel 1 type is genotype 42 as well. The genotypes for most of the B. melitensis isolates in this series and their close relatedness by MLVA (single-locus variants and in some cases double-locus variants) compared to the relatedness of B. melitensis isolates in other countries reflects microevolution within the regionally important strain due to a few mutational events [3]. We also observed that strains from the north and east of China (eg., Inner Mongolia and Shanxi) had the same MLVA-16 genotype (010) as those from the south of China (eg., Guangdong). This data indicates that the emergence of brucellosis in the south of China is likely to have its origins from the importation of animals from elsewhere in China. The clustering of epidemiologically-related isolates identified in the current and previous studies support the use of MLVA-16 as a valuable tool for investigations of outbreaks of both human and animal brucellosis. In our study, only 4 of 105 isolates (3.8%) had MLVA-16 genotype 030. It is likely that these cases represented a common-source outbreak or infected the herds of the same genotype. Because consistent epidemiological information for the strains is not routinely available, it is impossible to assess the relationship of the cluster results for these data and outbreaks. An urgent integrated, laboratory-based surveillance is needed to address this important public health gap. To facilitate outbreak investigation, it has been recommended to use an abbreviated MLVA scheme, omitting testing with panel 1 and 2A since panel 2B is highly polymorphic and potentially more discriminating in determining genetic relationships in regions of endemicity [14]. Some apparently unlinked (epidemiologically or otherwise) isolates had identical MLVA-16 profiles also. This led us to hypothesize that these may represent either epidemiologically unrelated isolates with homoplasy at MLVA-16 loci (most likely panel 2B) or persistent circulating strains causing sporadic infections [3,14]. More detailed genetic investigations such as whole genome sequence comparison, should clarify these relationships. Results of genotyping confirmed a laboratory-acquired Brucella infection. Laboratory workers who handle infected specimens are at high risk of acquiring Brucella infection, as suggested by the numerous cases of laboratory-acquired brucellosis reported in the literature [15]. We report a case of brucellosis affecting a hospital microbiology laboratory technician in Beijing, a non-endemic area of China. Human infection with the vaccine strain M5 in China has not been reported. However, in the previous reports, strains were only biotyped using conventional methods and no direct molecular linkage was shown between the isolated and commercial M5 vaccine strain. In this study, LB 10-01 has the identical genotype with M5. This suggests that LB 10-01 might be that a wild-type biovar 1 evolved with a pattern identical to M5 or that the original strain from which M5 was developed still is transmitted. Results obtained by Garcia-Yoldi et al. confirmed B. melitensis vaccine strain Rev 1 group as assayed by MLVA is genetically very homogeneous [16].

Conclusion

In conclusion, the MLVA assay is very promising to be used as a simple molecular tool for genotypes distribution of Brucella isolates from an endemic region, and might be useful for trace back investigations in non-endemic areas.

Methods

Bacterial strains and DNA preparation

A total of 104 B. melitensis strains used in the study were isolated from clinical samples (102 from blood, and 2 from bone marrow). The samples were collected as part of standard patient care between 1957 and 2010 and were fully de-identified. So any ethical approval was not required for the use of these samples. B. melitensis biovar 1 vaccine strain M5 was also included in this study (Table 2). Bacterial isolates were cultured on Trypticase soy agar containing 5% sheep blood (BD Diagnostic Systems, China Ltd., China) at 37°C for 48 h. All isolates were identified as Brucella species (biovar) on the basis of classical identification procedures: CO2 requirement, H2S production, inhibition of growth by basic fuchsin and thionin, agglutination with monospecific antisera and phage typing [17]. Total genomic DNA was extracted with the DNeasy Blood & Tissue Kit (Qiagen China Ltd., China) by following the manufacturer's protocol for extraction of genomic DNA from Gram-negative bacteria. Species-level identification was undertaken by the AMOS-PCR assay [18].
Table 2

The 105 B. melitensis isolates examined in this study

Geographical originYearNo. of isolatesPanel 1Genotypes*
Inner Mongolia1955-20062642,63
Qinghai1965142
Henan1963,1982242,43
Shanxi1979-20091142,43,45,63
Shandong1973,2005342
Shan'xi1962,2008542
Hebei2009142
Liaoning2005242
Guangxi1961158
Zhejiang2005,2009342
Fujian2009342,58
Yunnan2009258
Beijing2006142
Guangdong2006-20103942, 43, 63, CN-1
Hunan2008142
Jilin1971142
Tianjin2010142
Shanghai2007163
Heilongjiang1962142

*genotype 42 (1-5-3-13-2-2-3-2), genotype 43 (1-5-3-13-3-2-3-2),

genotype 45 (1-5-3-12-2-2-3-2), genotype 58 (1-5-3-13-3-1-3-2)

genotype 63 (1-5-3-13-2-3-3-2), genotype CN-1 (1-5-3-13-2-1-3-2)

The 105 B. melitensis isolates examined in this study *genotype 42 (1-5-3-13-2-2-3-2), genotype 43 (1-5-3-13-3-2-3-2), genotype 45 (1-5-3-12-2-2-3-2), genotype 58 (1-5-3-13-3-1-3-2) genotype 63 (1-5-3-13-2-3-3-2), genotype CN-1 (1-5-3-13-2-1-3-2)

MLVA-16 genotyping scheme

MLVA was performed as previously described [11]. The sixteen primer pairs were divided into three groups as previously described: panel 1 (8 loci including bruce06, bruce08, bruce11, bruce12, bruce42, bruce43, bruce45, and bruce55), panel 2A (3 loci including bruce18, bruce19, and bruce21), and panel 2B (5 loci including bruce04, bruce07, bruce09, bruce16, and bruce30). PCR conditions were as follows: initial denaturation at 94°C for 3 min, and then 30 cycles of 94°C for 30 s, 60°C for 30 s and 72°C for 50 s. Five microliters of the amplification products were loaded in to 2% (panel 1) and 3% (panels 2A and 2B) agarose gels containing ethidium bromide (0.5 μg/ml), visualized under UV light, and photographed. The reference strain B. melitensis 16 M, for which the precise molecular mass is known for each primer pair locus, was used for size comparison. To determine the number of repeats from the sample products, PCR products were purified and directly sequenced using an ABI Prism Big Dye Terminator (v3.1) cycle sequencing ready reaction kit (v5.0). The PCR products of samples were sequenced and the sequences were compared to that of B. melitensis 16 M.

Analysis of MLVA data

All data were analyzed using BioNumerics version 5.1 software (Applied Maths, Belgium). Clustering analysis was based on the categorical coefficient and unweighted pair group method using arithmetic averages (UPGMA) method. Polymorphism at each loci was quantified using Nei's diversity index, available in the website of HPA http://www.hpa-bioinformatics.org.uk/cgi-bin/DICI/DICI.pl[19]. Resultant genotypes were compared using the web-based Brucella2010 MLVA database http://mlva.u-psud.fr/.

Authors' contributions

JH did most of the typing work and wrote the report. ZHY, TGZ and PDR prepared the DNA samples. FMG, MJC and YRP were in charge of epidemiological investigation and collection of Inner Mongolia strains. CJD, KCW and DXL were in charge of epidemiological investigation and collection of Guangdong strains. CBY managed the project. All authors read and approved the final manuscript.
  18 in total

Review 1.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

2.  Use of MLVA-16 typing to trace the source of a laboratory-acquired Brucella infection.

Authors:  C Marianelli; A Petrucca; P Pasquali; F Ciuchini; S Papadopoulou; P Cipriani
Journal:  J Hosp Infect       Date:  2008-03-04       Impact factor: 3.926

3.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  Epidemiology and control of brucellosis in China.

Authors:  Shang Deqiu; Xiao Donglou; Yin Jiming
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

5.  Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis.

Authors:  David García-Yoldi; Philippe Le Fleche; Clara M Marín; María J De Miguel; Pilar M Muñoz; Gilles Vergnaud; Ignacio López-Goñi
Journal:  Vaccine       Date:  2006-10-05       Impact factor: 3.641

6.  Evaluation of Brucella MLVA typing for human brucellosis.

Authors:  Sascha Al Dahouk; Philippe Le Flèche; Karsten Nöckler; Isabelle Jacques; Maggy Grayon; Holger C Scholz; Herbert Tomaso; Gilles Vergnaud; Heinrich Neubauer
Journal:  J Microbiol Methods       Date:  2007-01-03       Impact factor: 2.363

7.  Genetic comparison of Brucella canis isolates by the MLVA assay in South Korea.

Authors:  Sung-Il Kang; Eun Jeong Heo; Donghee Cho; Jong Wan Kim; Ji-Yeon Kim; Suk Chan Jung; Moon Her
Journal:  J Vet Med Sci       Date:  2011-02-07       Impact factor: 1.267

8.  Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR.

Authors:  B J Bricker; S M Halling
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

9.  Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.

Authors:  Cinzia Marianelli; Caterina Graziani; Carmela Santangelo; Maria Teresa Xibilia; Alida Imbriani; Rosa Amato; Domenico Neri; Mario Cuccia; Sebastiano Rinnone; Vincenzo Di Marco; Franco Ciuchini
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

10.  Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay.

Authors:  Philippe Le Flèche; Isabelle Jacques; Maggy Grayon; Sascha Al Dahouk; Patrick Bouchon; France Denoeud; Karsten Nöckler; Heinrich Neubauer; Laurence A Guilloteau; Gilles Vergnaud
Journal:  BMC Microbiol       Date:  2006-02-09       Impact factor: 3.605

View more
  28 in total

1.  A Familial Cluster of Human Brucellosis Attributable to Contact with Imported Infected Goats in Shuyang, Jiangsu Province, China, 2013.

Authors:  Zhongming Tan; Yong Huang; Genyan Liu; Weizhong Zhou; Xilou Xu; Zibing Zhang; Qing Shen; Fenyang Tang; Yefei Zhu
Journal:  Am J Trop Med Hyg       Date:  2015-07-06       Impact factor: 2.345

2.  Multiple-locus variable-number tandem-repeat analysis (MLVA) genotyping of human Brucella isolates in Malaysia.

Authors:  Bee Yong Tay; Norazah Ahmad; Rohaidah Hashim; Jama'ayah Mohamed Zahidi; Kwai Lin Thong; Xiu Pei Koh; Azura Mohd Noor
Journal:  BMC Infect Dis       Date:  2015-06-02       Impact factor: 3.090

3.  MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and humans and identification of Brucella suis vaccine strain S2 from cattle in China.

Authors:  Hai Jiang; Heng Wang; Liqing Xu; Guiying Hu; Junying Ma; Pei Xiao; Weixing Fan; Dongdong Di; Guozhong Tian; Mengguang Fan; Jingchuan Mi; Ruiping Yu; Litao Song; Hongyan Zhao; Dongri Piao; Buyun Cui
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

4.  Human brucellosis in Maghreb: existence of a lineage related to socio-historical connections with Europe.

Authors:  Nedjma Lounes; Moulay-Ali Cherfa; Gilles Le Carrou; Abdellah Bouyoucef; Maryne Jay; Bruno Garin-Bastuji; Virginie Mick
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

5.  Genotyping of human Brucella melitensis biovar 3 isolated from Shanxi Province in China by MLVA16 and HOOF.

Authors:  Pei Xiao; Hongxia Yang; Dongdong Di; Dongri Piao; Qiuxiang Zhang; Ruie Hao; Suxia Yao; Rong Zhao; Fanfei Zhang; Guozhong Tian; Hongyan Zhao; Weixing Fan; Buyun Cui; Hai Jiang
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

6.  Within-host evolution of Brucella canis during a canine brucellosis outbreak in a kennel.

Authors:  Miklós Gyuranecz; Brandy D Rannals; Christina A Allen; Szilárd Jánosi; Paul S Keim; Jeffrey T Foster
Journal:  BMC Vet Res       Date:  2013-04-12       Impact factor: 2.741

7.  Molecular Epidemiology of Brucella abortus in Northern Ireland-1991 to 2012.

Authors:  Adrian Allen; Eleanor Breadon; Andrew Byrne; Thomas Mallon; Robin Skuce; Pauline Groussaud; Amanda Dainty; Judith Graham; Kerri Jones; Lorraine Pollock; Adrian Whatmore
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

8.  Brucella melitensis in France: persistence in wildlife and probable spillover from Alpine ibex to domestic animals.

Authors:  Virginie Mick; Gilles Le Carrou; Yannick Corde; Yvette Game; Maryne Jay; Bruno Garin-Bastuji
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

9.  Genetic polymorphism characteristics of Brucella canis isolated in China.

Authors:  Dongdong Di; Buyun Cui; Heng Wang; Hongyan Zhao; Dongri Piao; Lili Tian; Guozhong Tian; Jingli Kang; Xiang Mao; Xiaojun Zhang; Pengfei Du; Lin Zhu; Zhuo Zhao; Lingling Mao; Wenqing Yao; Pingyuan Guan; Weixing Fan; Hai Jiang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Assessment of genetic diversity of zoonotic Brucella spp. recovered from livestock in Egypt using multiple locus VNTR analysis.

Authors:  Ahmed M S Menshawy; Marta Perez-Sancho; Teresa Garcia-Seco; Hosein I Hosein; Nerea García; Irene Martinez; Ashraf E Sayour; Joaquín Goyache; Ragab A A Azzam; Lucas Dominguez; Julio Alvarez
Journal:  Biomed Res Int       Date:  2014-01-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.